Patrick D. Spangler - 30 Dec 2021 Form 4 Insider Report for OptimizeRx Corp (OPRX)

Role
Director
Signature
/s/ Patrick Spangler
Issuer symbol
OPRX
Transactions as of
30 Dec 2021
Transactions value $
$0
Form type
4
Filing time
03 Jan 2022, 15:45:19 UTC
Previous filing
15 Nov 2021
Next filing
01 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OPRX Restricted Stock Units Award $0 +409 +122.46% $0.00 743 30 Dec 2021 Common Stock 409 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F2 Grant to the Reporting Person of restricted stock units under the OptimizeRx Corp. 2021 Equity Incentive Plan. The restricted stock units granted vest on December 30, 2022, subject to continued service to the issuer through the vesting date. This restricted stock units granted are subject to accelerated vesting in the event that the recipient is subject to a qualified termination within a specified period of time prior to or following the closing of a change in control transaction.
F3 Not applicable.